mRNA |
Cyclopamine |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.01 |
mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.01 |
mRNA |
MST-312 |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.01 |
mRNA |
momelotinib |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.01 |
mRNA |
Sorafenib |
FIMM |
pan-cancer |
AAC |
-0.41 |
0.01 |
mRNA |
SB-525334 |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.01 |
mRNA |
SB52334 |
GDSC1000 |
pan-cancer |
AAC |
0.08 |
0.02 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.02 |
mRNA |
Crizotinib |
CTRPv2 |
pan-cancer |
AAC |
0.076 |
0.02 |
mRNA |
Topotecan |
CCLE |
pan-cancer |
AAC |
-0.1 |
0.02 |